(Q51376686)

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:21418455%20AND%20SRC:MED&resulttype=core&format=json

25 January 2020

title

Treatment with insulin detemir or NPH insulin in children aged 2-5 yr with type 1 diabetes mellitus (English)

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:21418455%20AND%20SRC:MED&resulttype=core&format=json

25 January 2020

0 references

1 reference

1 reference

1 reference

2

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:21418455%20AND%20SRC:MED&resulttype=core&format=json

25 January 2020

Nandu Thalange

1

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:21418455%20AND%20SRC:MED&resulttype=core&format=json

25 January 2020

author name string

Jens Larsen

3

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:21418455%20AND%20SRC:MED&resulttype=core&format=json

25 January 2020

Line Conradsen Hiort

4

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:21418455%20AND%20SRC:MED&resulttype=core&format=json

25 January 2020

Valentina Peterkova

5

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:21418455%20AND%20SRC:MED&resulttype=core&format=json

25 January 2020

publication date

21 March 2011

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:21418455%20AND%20SRC:MED&resulttype=core&format=json

25 January 2020

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:21418455%20AND%20SRC:MED&resulttype=core&format=json

25 January 2020

volume

12

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:21418455%20AND%20SRC:MED&resulttype=core&format=json

25 January 2020

issue

7

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:21418455%20AND%20SRC:MED&resulttype=core&format=json

25 January 2020

page(s)

632-641

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:21418455%20AND%20SRC:MED&resulttype=core&format=json

The effect of intensive treatment of diabetes on the development and progression of long-term complications in insulin-dependent diabetes mellitus. The Diabetes Control and Complications Trial Research Group

25 January 2020

cites work

1 reference

https://api.crossref.org/works/10.1111%2FJ.1399-5448.2010.00750.X

Risk of microalbuminuria and progression to macroalbuminuria in a cohort with childhood onset type 1 diabetes: prospective observational study.

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1399-5448.2010.00750.X

Overnight metabolic profiles in very young insulin-dependent diabetic children

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1399-5448.2010.00750.X

Insulin Detemir Is Characterized by a Consistent Pharmacokinetic Profile Across Age-Groups in Children, Adolescents, and Adults With Type 1 Diabetes

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1399-5448.2010.00750.X

Lower within-subject variability of insulin detemir in comparison to NPH insulin and insulin glargine in people with type 1 diabetes

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1399-5448.2010.00750.X

Insulin detemir used in basal-bolus therapy in people with type 1 diabetes is associated with a lower risk of nocturnal hypoglycaemia and less weight gain over 12 months in comparison to NPH insulin

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1399-5448.2010.00750.X

Insulin analogues (insulin detemir and insulin aspart) versus traditional human insulins (NPH insulin and regular human insulin) in basal-bolus therapy for patients with type 1 diabetes.

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1399-5448.2010.00750.X

Insulin detemir offers improved glycemic control compared with NPH insulin in people with type 1 diabetes: a randomized clinical trial

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1399-5448.2010.00750.X

Effects of QD insulin detemir or neutral protamine Hagedorn on blood glucose control in patients with type I diabetes mellitus using a basal-bolus regimen

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1399-5448.2010.00750.X

Insulin detemir compared with NPH insulin in children and adolescents with Type 1 diabetes.

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1399-5448.2010.00750.X

Therapy with insulin glargine (Lantus) in toddlers, children and adolescents with type 1 diabetes

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1399-5448.2010.00750.X

Effect of therapy with insulin glargine (lantus) on glycemic control in toddlers, children, and adolescents with diabetes

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1399-5448.2010.00750.X

Assessment and management of hypoglycemia in children and adolescents with diabetes

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1399-5448.2010.00750.X

British 1990 growth reference centiles for weight, height, body mass index and head circumference fitted by maximum penalized likelihood

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1399-5448.2010.00750.X

Long-term efficacy and safety of insulin detemir compared to Neutral Protamine Hagedorn insulin in patients with Type 1 diabetes using a treat-to-target basal-bolus regimen with insulin aspart at meals: a 2-year, randomized, controlled trial

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1399-5448.2010.00750.X

Insulin detemir is associated with more predictable glycemic control and reduced risk of hypoglycemia than NPH insulin in patients with type 1 diabetes on a basal-bolus regimen with premeal insulin aspart

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1399-5448.2010.00750.X

Impaired insulin action in puberty. A contributing factor to poor glycemic control in adolescents with diabetes.

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1399-5448.2010.00750.X

Hypoglycaemia: the limiting factor in the glycaemic management of Type I and Type II diabetes

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1399-5448.2010.00750.X

The Mechanism of Protraction of Insulin Detemir, a Long-Acting, Acylated Analog of Human Insulin

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1399-5448.2010.00750.X